Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort Study.

Burgevin, Alice; Caron, Bénédicte; Sasson, Alexa; Luc, Amandine; Netter, Patrick; Baumann, Cédric; Ananthakrishnan, Ashwin N; Peyrin-Biroulet, Laurent

Burgevin, Alice; Caron, Bénédicte; Sasson, Alexa; Luc, Amandine; Netter, Patrick; Baumann, Cédric; Ananthakrishnan, Ashwin N; Peyrin-Biroulet, Laurent.

Afiliação

Burgevin A; Department of Gastroenterology, University Hospital of Nancy, F-54000 Nancy, France.
Caron B; Department of Gastroenterology, University Hospital of Nancy, F-54000 Nancy, France.
Sasson A; NGERE (Nutrition-Génétique et Exposition aux Risques Environnementaux), U1256 INSERM, University of Lorraine, F-54000 Nancy, France.
Luc A; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
Netter P; Unit of Methodology, Data Management and Statistic, University Hospital of Nancy, F-54000 VandÅuvre-lès-Nancy, France.
Baumann C; Ingénierie Moléculaire et Ingénierie Articulaire (IMoPA), UMR-7365 CNRS, Faculté de Médecine, University Hospital of Nancy, University of Lorraine, F-54000 Vandoeuvre-lès-Nancy, France.
Ananthakrishnan AN; Unit of Methodology, Data Management and Statistic, University Hospital of Nancy, F-54000 VandÅuvre-lès-Nancy, France.
Peyrin-Biroulet L; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

J Clin Med ; 11(23)2022 Nov 25.

Article em En | MEDLINE | ID: mdl-36498541

Palavras-chave

Crohn's disease; biologics; older; safety; ulcerative colitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google